Home/Fry Laboratories/Judith (Judy) Joseph
J(

Judith (Judy) Joseph

Chief Executive Officer

Fry Laboratories

Fry Laboratories Pipeline

DrugIndicationPhase
RIDI™ SequencingInfectious Disease IdentificationCommercial
Lyme Disease and Coinfections DiagnosticsLyme DiseaseCommercial
Antibiotic Resistance by SequencingAntimicrobial Resistance ProfilingPre-clinical